Nuclein
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
8305 Cross Park Dr, Austin, Texas, 78754...Phone Number
(888) 992-3274Website
www.nuclein.comRevenue
$7.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Nuclein
Nuclein, LLC was founded in 2017 by experienced biotechnology entrepreneurs Alan Blake and Dr. Richard Crockett. The companys mission is to create a hand-held, disposable, all-in-one, self-test for infectious disease testing, which delivers battery-powered, sample-to-answer results within one hour, without the need to mail in a sample.Explore more
Nuclein Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nuclein your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Nuclein had a recent Job posting/layoffs
Product Launch: Get notified when Nuclein launches new products
Check out if Nuclein is spiking on competitors!
Check if Nuclein has recently received funding, and reach out quickly before it becomes old news!
Nuclein, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Nuclein recently announced quarterly report
Funding: Get notified immidiatlly once Nuclein has new funding data
Congratulate Masked Content for being promoted to Masked Content at Nuclein
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Nuclein
Find more new buyers
Compare Similar Companies to Nuclein
Compare insights from companies similar to Nuclein, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nuclein is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Nuclein is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Nuclein.
Nuclein financials insights
Gather financial insights about Nuclein, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$5.6M
2021
Series B
$14M
Nuclein Tech Stack
A closer look at the technologies used by Nuclein
Most Recent Scoops
Project
, according to a front-line source in accounting, is in the midst of initiatives related to agile accounting. P&B Partitions is expected to increase permanent employee workforce to support these efforts. The organization is evaluating Sage 100 in this area.
Analytics & Insights, Accounting, Financial Reporting, Finance
Project
, according to an internal source in accounting, is planning to begin initiatives related to payroll within three to six months. The organization is currently evaluating UKG Pro. Archdiocese of Philadelphia will be decreasing funding to support these efforts.
Spending/Investment, Accounting, Financial Planning, Compensation & Benefits, Financial Reporting, Finance
New Hire
Executive Move
Nuclein has announced that Mark Hunter has joined the organization as Vice President, Operations.
Open Position
Open Position
Nuclein News & Media
Nuclein's DASH® SARS-CoV-2 & Flu A/B Test for Use on the DASH® Rapid PCR System Receives FDA 510(k) Clearance and CLIA Waiver with Key Support from CovarsaDx® Research Team
LOS ANGELES, Jan. 7, 2025 /PRNewswire/ -- CovarsaDx®, a prominent Clinical Research Organization (CRO) renowned for its in vitro diagnostics (IVDs) and medical device expertise, announced today that one of its clinical research study clients, Nuclein, LLC, has received U.S. Food and Drug...Nuclein Receives Dual FDA 510(k) Clearance and CLIA Waiver for DASH® SARS-CoV-2 & Flu A/B Test for use on the DASH® Rapid PCR System
Rapid PCR Made Simple™: DASH® Delivers Lab-Quality Results in 15 Minutes AUSTIN, Texas, Jan. 6, 2025 /PRNewswire/ -- Nuclein, a leader in rapid, point-of-care molecular diagnostics, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance and a Clinical...Nuclein Closes $14M in Series B Funding
AUSTIN, TX, Nuclein has closed a $14 million Series B funding round, led by Trinity Private Equity Group
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nuclein
Sign Up For FreeTo access detailed company insights
Nuclein, LLC was founded in 2017 by experienced biotechnology entrepreneurs Alan Blake and Dr. Richard Crockett. The companys mission is to create a hand-held, disposable, all-in-one, self-test for infectious disease testing, which delivers battery-powered, sample-to-answer results within one hour, without the need to mail in a sample.... Read More
